Prostate cancer (PCa) is the fourth most common cancer in the world and treatment is currently based on surgical removal and/or radiotherapy and/or hormone therapy. In the last few years' immunotherapy has become an important cancer treatment option. While the principles of immunotherapy evolved,...
According to Dr. Raman, "This image-guided therapy maximizes our ability to killcancer cellswhile minimizingcollateral damageto the prostate to achieve the ultimate trifecta inprostate cancer treatment: full local cancer control while maintaining urinary continence and potency. The latter are the complic...
CHICAGO, June 4 (Xinhua) -- A combination of two existing prostate cancer therapies could extend lives of men with advanced, high-risk prostate cancer, a study showed. The addition of Zytiga to androgen-deprivation therapy can "significantly" increase overall survival in men with newly diagnosed,...
For the first time, researchers have discovered that prostate cancer can be killed by targeting a single enzyme, called PI5P4Kα. The findings, published recently inScience Advances, could help address the growing threat of treatment resistance in prostate cancer and could also lead to improved t...
Prostate Cancer – Medications: There have been three major new FDA approvals for prostate cancer diagnostics and treatments since the beginning of 2023: Akeega (niraparib and abiraterone acetate) – Janssen (August 2023) Treatment of adult patients with deleterious or suspected deleterious BRCA-posi...
“Enzalutamide is a much-needed development in prostate cancer treatment, and will provide a new option for the increasing number of men with advanced prostate cancer in the UK. Enzalutamide has already demonstrated a positive impact on quality of life while increasing the lifespan of patients. ...
In recent years the pace of research in prostate cancer has increased dramatically. Creative ideas in combination with new and emerging technologies have led to an explosion of discovery. These types of advances in prostate cancer research presage an era of new treatment strategies based on an unde...
doi:10.1038/nrurol.2013.232Grivas, Petros D.Keller, Evan T.Nature Reviews UrologyPetros D.Grivas, Evan T.Keller. (2013) Prostate cancer: Radium-223: a new treatment option for bone-metastatic CRPC. Nature Reviews Urology 10 , 630-631 /...
Prostate Cancer and Prostatic DiseasesBogdanos I,Karamanolakis D,Milathianakis C, et al.New strategies for the treatment of hormone-independent prostate cancer. J BUON . 2002Bogdanos et al. ' New strategies for the treatment of hormone-independent prostate cancer ', Journal of B.U.ON.: ...
000 die from prostate cancer (GLOBOCAN). There was over four times the incidence of prostate cancer in 2017 as in the 1950s, but at the same time, the treatments have been improving, so many more live longer, and die with, rather than of, prostate cancer. Nevertheless, more effective ...